Comparative analysis of the results of surgical treatment for pulmonary metastases from colorectal cancer and metastases from other primary origin Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016
What are oligometastases? Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts Year: 2016
MET genetic lesions in NSCLC are functional markers of early hematogenous spreading and radioresistance Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015
Our results of stereotactic radiotherapy in advanced stage lung cancer patients Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Results of stereotactic radiation therapy (SRT) on unique cerebral metastases from lung adenocarcinomas Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015
Single-institution experience of surgical management of metastasises of colorectal cancer in lungs: Lessons learned Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013
Locally advanced stage nonsmallcell cancers explode in hyperglisemia: A new prognostic factors? Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016
Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy? Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Contribution of adjuvant chemotherapy in stage I pulmonary adenocarcinoma after surgical resection Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016
Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
Genetics, pathology, and therapy of neuroendocrine tumours of the lung Source: International Congress 2017 – ME3 Genetics, pathology and therapy of neuroendocrine tumours of the lung Year: 2017
Clinico-pathological prognostic factors for relapse in early stage non-small cell lung cancer after radical surgical resection Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013
Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015
Salvage lung resection for local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers Source: Annual Congress 2011 - General thoracic surgery I Year: 2011
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the thoracic surgeon Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019
Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first? Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014
Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor? Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016
Clinical features and prognosis of multiple primary malignancies in patients with lung cancer Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013